CINTAS CORP
CTASNASDAQ🏆 #157 by market capEarnings Dec 17US Equity
$212.78▼ $2.08 (−0.97%)
After hours · at closeTrack CTAS
Get earnings, price moves & breaking news on Telegram
24h▼ 1.0%
7d▼ 3.3%
14d▲ 2.0%
30d▲ 6.1%
ytd▲ 13.1%
1y▲ 12.1%
🏦Market Cap
$84.49B
Mid Cap
📈Revenue Growth (YoY)
9.5%
Slowing
📊Gross Margin
51.0%
Healthy
💵FCF Margin
17.6%
Healthy
⚖️P/S Ratio
7.7x
Fair
Otter Score
76
Strong
CINTAS CORP
CTASAnalyst Ratings
Price
$212.78
Total
30
Raised
2
Lowered
4
Avg PT
$234.60
H / L
$250 / $222
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Citigroup | Reiterated | Sell | 2026-09-30 | — | — |
Argus Research | Reiterated | Buy | 2026-09-29 | $240.00 | +12.80% |
UBS | Reiterated | Buy | 2026-09-24 | $230.00 | +8.10% |
RBC Capital | Reiterated | Sector Perform | 2026-09-24 | $206.00 | −3.20% |
Baird | Reiterated | Outperform | 2026-09-24 | — | — |
Truist Securities | Reiterated | Buy | 2026-09-24 | — | — |
Wells Fargo | Reiterated | Overweight | 2026-07-16 | $250.00 | +17.50% |
B of A Securities | Upgraded | Neutral → Buy | 2026-07-16 | — | — |
Stifel | Reiterated | Hold | 2026-03-26 | — | — |
Morgan Stanley | Reiterated | Equal Weight | 2025-12-17 | $210.00 | −1.30% |
JP Morgan | Reiterated | Overweight | 2025-09-25 | $640.00 | +200.80% |
Goldman Sachs | Reiterated | Buy | 2025-07-02 | $231.00 | +8.60% |
Barclays | Reiterated | Overweight | 2024-09-27 | $210.00 | −1.30% |
Jefferies | Reiterated | Hold | 2024-09-26 | $448.00 | +110.60% |
CFRA | Reiterated | Strong Sell → Sell | 2024-09-12 | $170.00 | −20.10% |
Oppenheimer | Reiterated | Perform | 2024-04-01 | — | — |
Deutsche Bank | Reiterated | Hold | 2024-03-28 | $465.00 | +118.50% |
Credit Suisse | Reiterated | Neutral | 2021-07-16 | $375.00 | +76.20% |
William Blair | Downgraded | Outperform → Market Perform | 2020-04-06 | — | — |
Stifel Nicolaus | Reiterated | Hold | 2019-09-25 | $798.00 | +275.00% |
Nomura | Reiterated | Neutral | 2019-07-22 | — | — |
Bank of America | Upgraded | Neutral → Buy | 2019-01-03 | — | — |
Nomura Instinet | Downgraded | Buy → Neutral | 2017-06-27 | — | — |
Instinet | Downgraded | Buy → Neutral | 2017-06-27 | — | — |
Keybanc | Reiterated | Overweight | 2016-10-03 | — | — |
KeyBanc | Reiterated | Overweight | 2016-10-03 | — | — |
Macquarie | Reiterated | Neutral | 2016-08-25 | — | — |
Sterne Agee CRT | Reiterated | Neutral | 2016-03-22 | — | — |
PiperJaffray | Reiterated | Neutral | 2013-11-18 | — | — |
Barrington Research | Downgraded | Outperform → Market Perform | 2012-07-17 | — | — |
Institution
Citigroup
Reiterated · Sell · 2026-09-30
—
—
Argus Research
Reiterated · Buy · 2026-09-29
$240.00
+12.80%
UBS
Reiterated · Buy · 2026-09-24
$230.00
+8.10%
RBC Capital
Reiterated · Sector Perform · 2026-09-24
$206.00
−3.20%
Baird
Reiterated · Outperform · 2026-09-24
—
—
Truist Securities
Reiterated · Buy · 2026-09-24
—
—
Wells Fargo
Reiterated · Overweight · 2026-07-16
$250.00
+17.50%
B of A Securities
Upgraded · Neutral → Buy · 2026-07-16
—
—
Stifel
Reiterated · Hold · 2026-03-26
—
—
Morgan Stanley
Reiterated · Equal Weight · 2025-12-17
$210.00
−1.30%
JP Morgan
Reiterated · Overweight · 2025-09-25
$640.00
+200.80%
Goldman Sachs
Reiterated · Buy · 2025-07-02
$231.00
+8.60%
Barclays
Reiterated · Overweight · 2024-09-27
$210.00
−1.30%
Jefferies
Reiterated · Hold · 2024-09-26
$448.00
+110.60%
CFRA
Reiterated · Strong Sell → Sell · 2024-09-12
$170.00
−20.10%
Oppenheimer
Reiterated · Perform · 2024-04-01
—
—
Deutsche Bank
Reiterated · Hold · 2024-03-28
$465.00
+118.50%
Credit Suisse
Reiterated · Neutral · 2021-07-16
$375.00
+76.20%
William Blair
Downgraded · Outperform → Market Perform · 2020-04-06
—
—
Stifel Nicolaus
Reiterated · Hold · 2019-09-25
$798.00
+275.00%
Nomura
Reiterated · Neutral · 2019-07-22
—
—
Bank of America
Upgraded · Neutral → Buy · 2019-01-03
—
—
Nomura Instinet
Downgraded · Buy → Neutral · 2017-06-27
—
—
Instinet
Downgraded · Buy → Neutral · 2017-06-27
—
—
Keybanc
Reiterated · Overweight · 2016-10-03
—
—
KeyBanc
Reiterated · Overweight · 2016-10-03
—
—
Macquarie
Reiterated · Neutral · 2016-08-25
—
—
Sterne Agee CRT
Reiterated · Neutral · 2016-03-22
—
—
PiperJaffray
Reiterated · Neutral · 2013-11-18
—
—
Barrington Research
Downgraded · Outperform → Market Perform · 2012-07-17
—
—
One row per institution · price target from the firm's latest published target